Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Asset Writedowns and Impairment (2016 - 2025)

Balchem (BCPC) has disclosed Asset Writedowns and Impairment for 14 consecutive years, with $118000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 58.3% to $118000.0 in Q4 2025 year-over-year; TTM through Sep 2025 was $165000.0, a 97.94% decrease, with the full-year FY2024 number at $521000.0, down 93.29% from a year prior.
  • Asset Writedowns and Impairment was $118000.0 for Q4 2025 at Balchem, up from -$10000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $7.8 million in Q4 2023 to a low of -$132000.0 in Q3 2023.
  • A 5-year average of $443300.0 and a median of $60500.0 in 2021 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 35186.36% in 2023; the steepest drop was 13100.0% in 2023.
  • Balchem's Asset Writedowns and Impairment stood at $75000.0 in 2021, then plummeted by 70.67% to $22000.0 in 2022, then skyrocketed by 35186.36% to $7.8 million in 2023, then plummeted by 96.35% to $283000.0 in 2024, then crashed by 58.3% to $118000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Asset Writedowns and Impairment are $118000.0 (Q4 2025), -$10000.0 (Q3 2025), and -$29000.0 (Q2 2025).